These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8247629)

  • 21. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft.
    Elsen M; Soares M; Latinne D; Cornet A; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):447-9. PubMed ID: 8438373
    [No Abstract]   [Full Text] [Related]  

  • 22. W3/25+ and OX8+ T suppressor cells are required to maintain transplantation tolerance.
    Duncan WR; Bitter-Suermann H; Stepkowski SM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):551-2. PubMed ID: 2978924
    [No Abstract]   [Full Text] [Related]  

  • 23. Major histocompatibility complex-expressing human cardiac myocytes are not the direct target of host cardiac-infiltrating cells: evidence for a prominent role of the indirect pathway in human cardiac allograft rejection.
    Ansari AA; Kanter K; Wang YC; Mayne A; Sell KW; Herskowitz A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):89-93. PubMed ID: 8438502
    [No Abstract]   [Full Text] [Related]  

  • 24. Knock-out mice: a new tool for transplantation immunologists.
    Hergueux J; Bodmer H; Cardell S; Chan SH; Cosgrove D; Benoist C; Mathis D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):30-2. PubMed ID: 8438309
    [No Abstract]   [Full Text] [Related]  

  • 25. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
    Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
    [No Abstract]   [Full Text] [Related]  

  • 26. What guides MHC-restricted TCR recognition?
    Mazza C; Malissen B
    Semin Immunol; 2007 Aug; 19(4):225-35. PubMed ID: 17521918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J; Zhang L; Tang J; Jiang S; Wang X
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine kinase-dependent lymphocyte signaling during allograft rejection.
    Coles J; Tsao P; Wilson G; Mills G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):877. PubMed ID: 8442253
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protective effect of CD8+CD28- T suppressor cells on the acute rejection responses in rat liver transplantation.
    Liu Y; Chen N; Chen G; You P
    Transplant Proc; 2007 Dec; 39(10):3396-403. PubMed ID: 18089392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigens Act I: scene II.
    Weber R
    Dermatol Nurs; 2004 Apr; 16(2):206. PubMed ID: 15148914
    [No Abstract]   [Full Text] [Related]  

  • 33. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
    Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
    [No Abstract]   [Full Text] [Related]  

  • 34. Microglia, MHC expression and graft rejection.
    Lund RD; Banerjee R; Rao K
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):202-3. PubMed ID: 8072663
    [No Abstract]   [Full Text] [Related]  

  • 35. Human leukocyte antigen-G: immunotolerant major histocompatibility complex molecule in transplantation.
    Khalil-Daher I; Rouas-Freiss N; Carosella ED; Dausset JB
    World J Surg; 2000 Jul; 24(7):819-22. PubMed ID: 10833249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance.
    Jiang S; Herrera O; Lechler RI
    Curr Opin Immunol; 2004 Oct; 16(5):550-7. PubMed ID: 15341998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretion of soluble chemotactic factors, including interleukin-6: a mechanism for the recruitment of CD8-positive T lymphocytes to human liver allografts during rejection.
    Hathaway M; Burnett D; Elias E; Adams DH
    Hepatology; 1993 Sep; 18(3):511-8. PubMed ID: 8359794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
    del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
    Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.